Sino Biopharmaceutical Dividends and Buybacks
Dividend criteria checks 3/6
Sino Biopharmaceutical is a dividend paying company with a current yield of 1.79% that is well covered by earnings.
Key information
1.8%
Dividend yield
0.9%
Buyback Yield
| Total Shareholder Yield | 2.7% |
| Future Dividend Yield | 2.7% |
| Dividend Growth | 14.2% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | HK$0.060 |
| Payout ratio | 47% |
Recent dividend and buyback updates
Recent updates
After Leaping 27% Sino Biopharmaceutical Limited (HKG:1177) Shares Are Not Flying Under The Radar
Oct 02
Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly
Sep 02Are Investors Undervaluing Sino Biopharmaceutical Limited (HKG:1177) By 48%?
Jul 12Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly
May 21Sino Biopharmaceutical Limited's (HKG:1177) 27% Cheaper Price Remains In Tune With Earnings
Apr 21What Does The Future Hold For Sino Biopharmaceutical Limited (HKG:1177)? These Analysts Have Been Cutting Their Estimates
Apr 03Sino Biopharmaceutical Limited's (HKG:1177) Intrinsic Value Is Potentially 34% Above Its Share Price
Mar 20Sino Biopharmaceutical Limited's (HKG:1177) Shares May Have Run Too Fast Too Soon
Dec 18Does Sino Biopharmaceutical (HKG:1177) Have A Healthy Balance Sheet?
Dec 02Sino Biopharmaceutical Limited (HKG:1177) Shares Could Be 41% Below Their Intrinsic Value Estimate
Nov 17We Think Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt With Ease
Aug 30Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 50% Undervaluation?
May 26Sino Biopharmaceutical (HKG:1177) Has A Rock Solid Balance Sheet
Apr 20Is Sino Biopharmaceutical Limited (HKG:1177) Trading At A 38% Discount?
Feb 09Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 41% Undervaluation?
Nov 11Sino Biopharmaceutical (HKG:1177) Seems To Use Debt Quite Sensibly
Oct 24Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 46% Undervaluation?
Jul 08Is Sino Biopharmaceutical (HKG:1177) Using Too Much Debt?
Apr 28Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 1177's dividend payments have been volatile in the past 10 years.
Growing Dividend: 1177's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Sino Biopharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (1177) | 1.8% |
| Market Bottom 25% (HK) | 3.3% |
| Market Top 25% (HK) | 8.1% |
| Industry Average (Pharmaceuticals) | 3.8% |
| Analyst forecast (1177) (up to 3 years) | 2.7% |
Notable Dividend: 1177's dividend (1.79%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (3.3%).
High Dividend: 1177's dividend (1.79%) is low compared to the top 25% of dividend payers in the Hong Kong market (8.06%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (47.2%), 1177's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (18.4%), 1177's dividend payments are well covered by cash flows.